Candel Therapeutics, Inc. - stock earnings
CADL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -8.4 million USD | ? USD |
| 2023Q2 | -9.6 million USD | ? USD |
| 2023Q1 | -7.9 million USD | ? USD |
| 2022Q4 | 10.7 million USD | 31000 USD |
| 2022Q3 | -8.5 million USD | 31000 USD |
| 2022Q2 | 455000 USD | 31000 USD |
| 2022Q1 | 7.2 million USD | 31000 USD |
| 2021Q4 | 1.6 million USD | 31000 USD |
| 2021Q3 | -16.2 million USD | 31000 USD |
| 2021Q2 | -17.1 million USD | 31000 USD |
| 2021Q1 | -4.5 million USD | 31000 USD |
| 2020Q4 | -10.5 million USD | 31000 USD |
| 2020Q3 | -2.6 million USD | 31000 USD |
| 2020Q2 | -2.9 million USD | 31000 USD |
| 2020Q1 | -1.8 million USD | 31000 USD |
CADL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -31.9 million USD | 31000 USD |
| 2022 | -2.9 million USD | 125000 USD |
| 2021 | -36.1 million USD | 125000 USD |
| 2020 | -22.2 million USD | 125000 USD |
| 2019 | -8.0 million USD | 125000 USD |
CADL
Price: $9.02
52 week price:
Earnings Per Share: -1.31 USD
P/E Ratio: -1.54
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 14500
Market Capitalization: 195.5 million